{"filings":[{"id":1692758,"accession_number":"0001477932-26-004357","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2026-07-16T20:35:18+00:00","items":["3.03","5.03","5.02","5.07","9.01"],"status":"ready","headline":"Cosmos Health shareholders elect directors, approve Series B Preferred Stock and 2026 Equity Plan at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected with 79-84% affirmative votes.","Ratification of independent auditor approved with 84.24% affirmative.","2026 Equity Omnibus Plan approved with 79.58% affirmative.","Issuance of 100,000 shares of Series B Preferred Stock approved with 78.98% affirmative.","Approximately 47% of outstanding shares voted at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1455636,"accession_number":"0001477932-26-004192","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2026-07-06T13:30:49+00:00","items":["8.01","7.01","9.01"],"status":"ready","headline":"Cosmos Health authorizes up to $5M share repurchase program, representing ~50% of market cap","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $5M of common stock over 6 months ending Dec 31, 2026.","CEO cites record revenue, improving margins, US expansion, and animal healthcare entry as confidence drivers.","Program size equals nearly half of market capitalization as of June 29, 2026.","Repurchases may be made via open market, private transactions, or Rule 10b5-1 plans.","Timing and amount depend on market conditions, price, and regulatory requirements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":593356,"accession_number":"0001477932-26-003403","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2026-05-22T13:30:32+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cosmos Health Q1 revenue +31% to $17.93M; net loss widens to $2.81M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $17.93M, up 31% YoY from $13.71M; adjusted revenue $18.40M (+34.2%).","Net loss of ($2.81M) vs ($0.82M) in Q1 2025, driven by $1.15M in non-cash items.","Total liabilities reduced $4.5M (-9.6%) to $42.54M; stockholders' equity up 7.6% to $19.83M.","Adjusted EBITDA near breakeven at ($229,596); company expects positive EBITDA as revenues scale.","Strategic investments in U.S. expansion via 18 Series platform; Q2 momentum continues."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":17927892.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93048,"accession_number":"0001477932-26-002316","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cosmos Health reports record FY2025 revenue $65.3M, up 20%; gross profit +83%, adjusted EPS improves 82%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $65.3M (+20% YoY); gross profit $7.9M (+83%); gross margin 12.1% (+418 bps).","Adjusted EPS improved to ($0.12) from ($0.65) (+82%); adjusted EBITDA loss narrowed to $3.36M.","Cash and equivalents $3.5M, up 10x from $0.3M; total assets $65.5M (+21%).","CEO Greg Siokas increased ownership by 3.3M shares; secured $300M digital asset financing facility.","Contract manufacturing deals for 12M+ units; Sky Premium Life 60 new SKUs; U.S. expansion with NOOR Collagen."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120653,"accession_number":"0001477932-25-009040","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cosmos Health receives Nasdaq bid-price deficiency notice; 180-day cure period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received non-compliance letter on Dec 11, 2025 for bid price below $1.00 for 30 consecutive business days.","Has 180 calendar days to regain compliance by closing at $1.00 for at least 10 consecutive business days.","Company intends to effect a reverse stock split if it cannot otherwise meet the listing rule.","An indicator will be displayed on NASDAQ quotation information for COSM shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120652,"accession_number":"0001477932-25-008402","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cosmos Health Q3 2025 revenue $17.1M (+38% YoY), record gross margin 15.2%, cash jumps to $4.63M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2025 revenue $17.11M (up 38% YoY); gross profit $2.60M (+116%), gross margin 15.21% (vs 9.72%).","Adjusted EBITDA loss narrowed 74% to ($0.19M); adjusted EPS $(0.02) vs $(0.34) a year ago.","Cash and cash equivalents surged to $4.63M from $0.66M at June 30, 2025.","Secured $300M digital financing facility and commenced Ethereum purchases.","Contract manufacturing agreement for 3M MYCOFAGYL pessaries annually; Sky Premium Life enters Oman."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":45568655.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120651,"accession_number":"0001477932-25-007629","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Cosmos Health regains compliance with Nasdaq minimum bid price requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Oct 15, 2025 confirming compliance with Minimum Bid Price Rule.","Closing bid price was at or above $1.00 for 18 consecutive business days (Sep 22 - Oct 15, 2025).","Compliance achieved organically; CEO cites strategic initiatives and strengthened fundamentals.","Nasdaq has closed the matter; no further action required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120650,"accession_number":"0001477932-25-007365","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cosmos Health appoints Theodoros Karkantzos to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed effective September 30, 2025, term expiring at 2026 annual meeting.","Also appointed to Nominating and Corporate Governance Committee.","Annual cash board fee $10,000; committee fee $5,000; equity under 2025 Omnibus Plan.","Karkantzos has 15+ years investment/business development experience; co-founded Blue Dot Digital Agency.","No prior transactions with the company other than unpaid consulting via C Capital Media."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120649,"accession_number":"0001477932-25-007274","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-10-01T23:59:59+00:00","items":["5.02","5.07","5.03","9.01"],"status":"ready","headline":"Cosmos Health shareholders approve 1.5B common share increase and reverse split authorization at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected six directors: Siokas, Demetriades, Hoidas, Aslidis, Bhutawala, Karkantzos with majority votes.","Approved increase of authorized common stock to 1.5B shares and preferred stock to 300M shares (13.8M for).","Authorized board to effect reverse stock split at its discretion (13.9M for).","Approved issuance of shares upon conversion of notes under Nasdaq Listing Rule 5635(d) (13.96M for).","Ratified auditor, approved 2025 Equity Omnibus Plan, and set non-binding say-on-pay frequency at three years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137239,"accession_number":"0001477932-25-007111","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cosmos Health CEO letter details $300M digital asset facility, H1 revenue up 11.7%, 2027 guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Secured $300M senior secured convertible note; 72.5% net proceeds to digital treasury (ETH, BTC, SOL).","H1 2025 revenue $28.46M (+11.7% YoY); gross profit $3.21M (+53%).","2024 revenue $54.43M (+2%); net loss ($4.74M); adjusted EBITDA ($3.73M).","2027 targets: revenue ~$155.8M, adj. EBITDA ~$29.4M, positive operating cash flow.","Sky Premium Life expanded to US, UAE, Qatar, Central Europe; now 150+ SKUs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137238,"accession_number":"0001477932-25-005628","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-08-11T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Cosmos Health closes $8M senior secured convertible note with 9% OID, conversion at $1.05","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $8M original principal 9% senior secured convertible note to institutional investor on August 7, 2025.","Note matures August 7, 2027; interest 9% p.a., payable monthly in stock or cash at company's option.","Conversion price initially $1.05 per share, subject to market price adjustment; beneficial ownership cap 4.99% (up to 9.99%).","Note ranks senior to all existing and future debt except permitted indebtedness; secured by permitted liens.","Offered in private placement under Section 4(a)(2); proceeds not specified but typical for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137237,"accession_number":"0001477932-25-005501","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Cosmos Health secures up to $300M convertible note facility for Ethereum treasury strategy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Up to $300M in 9% senior secured convertible notes; initial $8M close on Aug 6, 2025.","72.5% of net proceeds to be used to acquire Ethereum (ETH) as a digital asset treasury reserve.","Shares convertible at market-based pricing; beneficial ownership cap of 4.99% (can increase to 9.99%).","Company must call shareholder meeting within 60 days to approve increase in authorized shares to 1.5B.","Remaining proceeds for working capital, R&D, and U.S. manufacturing expansion; Curvature Securities placement agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154538,"accession_number":"0001477932-25-003402","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cosmos Health receives Nasdaq extension to Nov 3, 2025 for minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq granted 180-day extension through Nov 3, 2025 to meet $1.00 minimum bid price rule.","Company was previously notified of non-compliance on Nov 6, 2024; initial period ended May 5, 2025.","To regain compliance, closing bid must be at least $1.00 for 10 consecutive business days.","CEO Greg Siokas expressed confidence in meeting listing requirements within extended timeframe."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173088,"accession_number":"0001477932-25-001107","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cosmos Health postpones S-1 offering until after 2024 10-K filing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cosmos Health will not proceed with its Form S-1 offering until after filing the 2024 Annual Report on Form 10-K.","The decision is disclosed via press release dated February 18, 2025; no reasons or financial impact provided.","The delay postpones potential equity capital raise, but no timeline for resumption given."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173087,"accession_number":"0001477932-25-000519","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-01-29T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"Cosmos Health subsidiary CosmoFarm issues €2.2M secured bond at Euribor+2.95%, matures 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["CosmoFarm S.A. issued €2.2M ($2.29M) secured bond from a European bank on Jan 27, 2025.","Loan split into Series A (€700k, 10 semi-annual installments) and Series B (€1.5M, bullet at maturity).","Interest rate: 2.95% + 6-month Euribor, payable semi-annually; maturity January 27, 2030.","Proceeds for strategic growth, working capital; bond secured by CosmoFarm's building.","Company retains option to upsize the bond issuance to raise additional non-dilutive capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173086,"accession_number":"0001477932-25-000373","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2025-01-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cosmos Health enters exclusive license for two cancer-treatment patents; up to EUR 7.5M buy-out","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exclusive worldwide license for two patents (filed 2016, 2017) to treat cancer; commercialize via R&D and trials.","Initial payment $500K by Dec 31, 2024; fixed EUR 350K/year 2025-2030; thereafter 1.5% of Net Sales.","Buy-out option to acquire patents for total EUR 7,500,000 (EUR 4M for Patent 1, EUR 3.5M for Patent 2).","Licensor DocPharma is a related party; agreement governed by New York law; term for life of patents or 20 years.","Cosmos has right to sublicense and terminate for convenience after 5 years; Licensor can terminate for uncured breach."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190110,"accession_number":"0001477932-24-007534","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cosmos Health shareholders approve reverse split authorization, elect directors at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected; Grigorios Siokas received 90.6% approval, John Hoidas lowest at 69.4%.","Authorization granted to board for reverse stock split at its discretion with 92.4% shareholder support.","2024 Omnibus Equity Incentive Plan approved with 78.3% of votes cast in favor.","Ratification of independent auditor (Deloitte?) passed with 99.7% affirmative votes.","Issuance of shares under warrant inducement approved with 70.4% support."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190109,"accession_number":"0001477932-24-007041","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cosmos Health receives Nasdaq bid price deficiency notice; 180-day cure period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Cosmos Health of non-compliance with minimum $1.00 bid price rule as of Nov 6, 2024.","Company has 180 calendar days from Nov 6, 2024 to regain compliance by closing bid price >= $1.00 for 10 consecutive days.","Company may effect a reverse stock split if unable to regain compliance otherwise.","Nasdaq will display a non-compliance indicator for COSM securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206609,"accession_number":"0001477932-24-005967","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Cosmos Health enters warrant exchange agreement, issues 9.7M new warrants at $0.95","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Holder exercised 4,874,126 December 2023 warrants at reduced price of $0.8701 per share.","Company issued 9,748,252 new 2024 warrants (Series A & B) exercisable after stockholder approval.","Series A warrants have 5-year term; Series B warrants have 18-month term; both at $0.95 strike.","A.G.P./Alliance Global Partners acted as financial advisor for the inducement transaction.","New warrants are unregistered securities issued under Section 4(a)(2) and Regulation D."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206608,"accession_number":"0001477932-24-004310","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-07-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cosmos Health regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notification on July 19, 2024 that it regained compliance with Listing Rule 5550(a)(2).","Closing bid price was $1.00 or greater for ten consecutive business days from July 5 to July 18, 2024.","CEO Greg Siokas stated compliance was achieved organically without a reverse stock split.","Nasdaq has closed the matter; no further action required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223784,"accession_number":"0001477932-24-003315","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K/A","filed_at":"2024-05-28T23:59:59+00:00","items":["4.01","3.01","9.01"],"status":"ready","headline":"Cosmos Health receives additional Nasdaq delinquency notice for late 10-K and 10-Q filings","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq delinquency letter on May 21, 2024 for failure to timely file Q1 2024 Form 10-Q and remaining delinquent on 2023 Form 10-K.","Must submit compliance plan by June 17, 2024; if accepted, extension possible until October 14, 2024.","Dismissed auditor KPMG on April 26, 2024; appointed RBSM LLP on May 21, 2024 after formal acceptance.","KPMG flagged potential illegal act involving third-party vendor; company disputes, says independent inventory count substantiated the transaction.","No immediate effect on Nasdaq listing; shares continue trading under symbol COSM."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223783,"accession_number":"0001477932-24-002502","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K/A","filed_at":"2024-05-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cosmos Health dismisses KPMG amid dispute over inventory transactions; appoints RBSM","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KPMG dismissed on April 26, 2024 after failing to complete 2023 audit timely; cites unresolved inventory concerns.","KPMG claims it identified transactions suggesting an illegal act may have occurred and requested investigation.","Company denies KPMG raised illegal-act claim; says independent inventory count on April 30 validated the transactions.","RBSM LLP appointed as new auditor on April 29, 2024 to audit FY 2023 financials, subject to client acceptance.","Audit Committee informed on April 10 that KPMG suspended work, causing delay in filing Form 10-K for 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223782,"accession_number":"0001477932-24-002483","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K/A","filed_at":"2024-05-02T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cosmos Health dismisses KPMG, hires RBSM; KPMG flags possible illegal act, company disagrees","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed KPMG as auditor immediately on April 26, 2024; KPMG unable to complete 2023 audit on time.","KPMG says it identified transactions with a third-party consignment vendor suggesting an illegal act may have occurred and requested investigation.","Company disputes; says KPMG never said 'illegal act,' and inventory count on Apr 30 substantiated transaction.","Appointed RBSM LLP as new independent auditor on April 29, 2024 to audit fiscal year 2023 financial statements.","KPMG suspended audit work Apr 10; company unable to timely file Form 10-K for FY2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223787,"accession_number":"0001477932-24-002352","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cosmos Health dismisses KPMG as auditor; KPMG unable to complete FY2023 audit on time","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed KPMG effective April 26, 2024; Audit Committee unanimous vote.","KPMG appointed August 2023 for Q3 review and FY2023 audit but could not complete on timely basis.","No disagreements or reportable events during KPMG's tenure from August 2023 through April 2024.","Company will file KPMG's letter to SEC as Exhibit 16.1 by amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223786,"accession_number":"0001477932-24-002332","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["1.01","3.03","9.01"],"status":"ready","headline":"Cosmos Health adopts shareholder rights plan (poison pill) with 20% trigger","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board declared dividend of one right per common share outstanding as of April 19, 2024.","Rights become exercisable (flip-in) if any person acquires 20%+ of voting shares without board approval.","Exercise price $0.001 per share; each right permits purchase of shares worth twice exercise price upon flip-in.","Rights redeemable by board at $0.001 per right prior to flip-in event.","Rights Agreement has five-year term, subject to shareholder ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223785,"accession_number":"0001477932-24-002262","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-04-19T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cosmos Health receives Nasdaq late-filing notice for 2023 10-K; 60 days to submit compliance plan","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice received April 17, 2024 for failure to file annual Form 10-K for FY 2023 by due date.","Company has 60 calendar days to submit a plan to Nasdaq; extension up to 180 days possible if plan accepted.","No immediate impact on listing, but a non-compliance indicator will be broadcast.","CEO Greg Siokas states team is working diligently to regain compliance in short order.","If plan is rejected, company can appeal to a Nasdaq hearings panel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243191,"accession_number":"0001477932-24-001429","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"Cosmos Health receives Nasdaq bid-price deficiency notice; 180 days to cure","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified company on March 20, 2024 that bid price closed below $1.00 for 30 consecutive days.","Company has 180 calendar days (to ~Sept 16, 2024) to regain compliance by having bid price ≥ $1.00 for 10 consecutive days.","If unable to comply, company intends to effect a reverse stock split to regain compliance.","A deficiency indicator will be displayed on Nasdaq for the company's common stock (COSM).","The notice does not affect listing immediately; trading continues normally during cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243190,"accession_number":"0001477932-24-000313","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2024-01-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cosmos Health acquires 10 generic drug portfolio for $3.5M from related party","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired licenses/rights to 10 generic drugs from related party for €3.2M ($3.5M).","Drugs target diabetes, cholesterol, respiratory, cardiac conditions and more.","Manufacturing to occur at Cosmos' wholly-owned subsidiary Cana Laboratories.","Global generic drugs market valued at $411.99B in 2022, projected to $613.34B by 2030.","CEO says acquisition supports transition to full-fledged pharmaceutical company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260594,"accession_number":"0001477932-23-009401","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-12-29T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Cosmos Health projects $12.5M+ revenue from 2023 acquisitions; exchanges warrants at $1.45","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered warrant exchange for 4,874,126 new shares at $1.45 (down from $2.75); AGP gets $215K fee.","FY 2024 incremental revenue from 2023 acquisitions (Cana, Bikas, ZipDoctor) projected at $12.5M+ vs FY 2022.","FY 2024 gross profit from these acquisitions expected at $3.1M+; EBITDA >$1.3M (margin >10.4%).","FY 2023 incremental revenue from acquisitions estimated at ~$4M (under 6 months contribution).","Acquisitions added $15.5M in assets and $1.7M bargain purchase gain; carry zero debt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260589,"accession_number":"0001477932-23-009424","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K/A","filed_at":"2023-12-29T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Cosmos Health enters warrant exchange at $1.45 strike; provides 2024 growth outlook","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Warrant exchange with one holder: new warrants for up to 4,874,126 shares at $1.45 (200% of existing warrants; prior strike $2.75).","Company to register new warrant shares within 30 days; AGP receives $215,000 flat fee plus expenses.","Business update: expects substantial revenue growth from 2023 acquisitions, with forecasts for revenue, gross profit, and EBITDA.","New warrants exercisable for 5 years from shareholder approval, issued under Section 3(a)(9) exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260593,"accession_number":"0001477932-23-008831","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-11-28T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Cosmos Health adopts clawback policy to meet Nasdaq listing rule","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted Clawback Policy on Nov 21, 2023, effective immediately.","Policy requires recoupment of excess incentive compensation from execs upon accounting restatement.","Covers cash bonuses, stock options, RSUs, and other awards tied to financial reporting measures.","Company will not indemnify executives for amounts recovered under the policy.","Standard governance adoption; no current restatement or clawback event triggered."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260592,"accession_number":"0001477932-23-008752","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-11-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cosmos Health Q3 2023: Revenue $12.8M (+7% YoY), net loss $3.35M, Adj. EBITDA -$1.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $12.8M (+7% YoY); gross margin declined to 9.5% from 14.9% due to logistics mix.","Net loss $3.35M vs $1.97M in Q3 2022; Adjusted EBITDA -$1.1M vs +$0.5M.","SG&A doubled to $4.0M on R&D, acquisition integration, stock-based comp, and provisions.","Total assets record $71.5M; stockholders' equity $44.2M ($3.4/share); debt reduced.","Reiterated 2026 guidance: >$180M revenue, >$20M EBITDA; plans to spin off R&D division."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":37537003.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260591,"accession_number":"0001477932-23-007528","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-10-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cosmos Health reports H1 2023 adjusted net income $3.01M, issues 2026 guidance of $180M revenue","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["H1 2023 Adjusted EBITDA of $3.01M (up 182% YoY) and Adjusted Net Income of $3.01M (up from -$0.09M loss).","Inaugural 2026 guidance: gross annual revenue exceeding $180M and EBITDA >$20M.","Completed three acquisitions in 2023: Cana Laboratories, Bikas GP (adds >$10M annual revenue), and ZipDoctor.","Book value per share >$4 (2.5x current price); unencumbered properties fair value >$12M (>50% market cap).","CEO Greg Siokas invested >$15M total, ~$850K YTD; share buyback up to $3M started Sept 13."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260590,"accession_number":"0001477932-23-007315","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cosmos Health receives Nasdaq reprimand for prior shareholder approval violation; matter closed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq issued a Letter of Reprimand on Sept 27, 2023, for failing to obtain prior shareholder approval for October 2022 public offering.","Offering involved units of common stock and warrants at a discount exceeding Nasdaq minimum price rules.","Company stated violation was inadvertent; 98% of votes at Dec 2022 meeting were affirmative had approval been sought.","Shareholder ratification obtained at Sept 18, 2023 annual meeting; no further action required.","Nasdaq noted no prior pattern of non-compliance; matter considered closed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277885,"accession_number":"0001477932-23-007031","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-09-22T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Cosmos Health CCO resigns; shareholders approve reverse split authorization and equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Chief Communications Officer Pavlos Ignatiades resigned effective Sept 20, 2023.","Shareholders elected all six director nominees with over 94% affirmative votes each.","Ratified October 2022 public offering (97.77% for) and approved 2023 equity incentive plan (94.19% for).","Board authorized to effect reverse stock split at its discretion; 97.67% of votes in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277884,"accession_number":"0001477932-23-006898","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cosmos Health targets FY2026 revenue >$180M and EBITDA >$20M; recaps 2023 milestones","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Inaugural 2026 guidance: gross annual revenue over $180M and EBITDA exceeding $20M.","Completed three acquisitions in 2023: Cana Laboratories, I. Bikas GP assets, and ZipDoctor telehealth.","Nutraceutical brands Sky Premium Life and Mediterranation expanding into new sales channels and geographies.","Maintains robust balance sheet with negligible debt; CEO's personal investment now exceeds $15M.","Second phase of obesity product CCX0722 completed; clinical trials scheduled to start in Q4 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277883,"accession_number":"0001477932-23-006179","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-08-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cosmos Health H1 2023 adjusted net income jumps 3550% to $3.01M, revenue down 6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2023 revenue $12.36M (-6.4% YoY); H1 revenue $24.71M (-6.0% YoY) on currency headwinds.","H1 adjusted net income $3.01M vs loss of $0.09M in H1 2022; adjusted EBITDA $3.01M (+182% YoY).","Book value per share exceeds $4.04; stockholders' equity up 12.9% to $44.35M.","Acquired Cana Laboratories (GMP certified) and Bikas distribution network (50 pharmacies, >$10M annual revenue expected).","Property & equipment up 488% to $10.7M; goodwill & intangibles up 435% to $3.78M from Q4 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":24713206.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277882,"accession_number":"0001477932-23-005797","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-08-07T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cosmos Health auditor Armanino resigns; KPMG hired; prior internal control weaknesses disclosed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Armanino LLP resigned effective upon engagement of new auditor or filing of Q3 10-Q, citing its transition away from public company audits.","Prior audit reports for FY2021 and 2022 were unqualified; no disagreements or reportable events occurred.","Material weaknesses in internal controls noted for FY2021/22: lack of segregation of duties, insufficient review, and inadequate ITGCs.","KPMG Certified Auditors (Athens, Greece) appointed Aug 7, 2023, to audit FY2023 financials and review Q3 10-Q.","No prior consultations with KPMG regarding disagreements or reportable events."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277881,"accession_number":"0001477932-23-005519","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-07-25T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Cosmos Health raises $5.25M via registered direct offering and private placement; CEO participates $450K","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 2,116,936 common shares, 715,323 pre-funded warrants, and 1,935,484 common warrants in a $5.25M offering.","Combined purchase price per share and warrant was $2.48; common warrant exercise price $2.75, expiring in 5 years.","CEO Grigorios Siokas invested $450,000 in common shares; no warrants issued to him.","Existing warrants on 782,610 shares amended: exercise price reduced from $11.50 to $2.75 per share.","Net proceeds primarily for working capital, general corporate purposes, and funding acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277880,"accession_number":"0001477932-23-005042","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-07-06T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Cosmos Health completes Cana buy for $1.67M; assets valued over $10M, expects gain","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $1.67M (€800k cash + $800k stock at $17.25/share) for 100% of Cana; closed June 30, 2023.","Cana's tangible and intangible assets independently valued >$10M; Cosmos expects substantial gain on bargain purchase.","Cana's 54,000 sq ft production facility added; prior acquisitions: Bikas GP (>$10M annual revenue) and ZipDoctor.","Binding LOI for German-based Docpharm; projected to add $30M annual revenue by 2025.","R&D clinical trials for obesity/weight management scheduled to start Q4 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295889,"accession_number":"0001477932-23-004119","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cosmos Health to acquire Docpharm GmbH for €800K cash plus €1M credit line","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price €800,000 in cash to Docpharm owners; additional €1,000,000 credit line for working capital.","Closing subject to due diligence, definitive SPA, board/stockholder approvals, and PCAOB-auditable financials.","Exclusivity through July 15, 2023; Docpharm is an ISO/GDP-certified German pharmaceutical distributor since 1995.","Current managing directors to remain; new service agreements with equal or better economic terms.","Cosmos to bear costs of due diligence and audit as part of the transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295888,"accession_number":"0001477932-23-003275","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cosmos Health signs SPA to buy Cana Holdings for €800k cash + $800k stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price: €800,000 cash and 46,377 restricted shares at $17.25/share ($800,000) paid pro rata to sellers.","Target is Pharmaceutical Laboratories Cana S.A., a Greek pharma company focused on branded products.","Closing conditions include due diligence, audited 2022 financials, debt cap of €1M (excl. prior €4.1M Note), and no material adverse changes.","Closing targeted by May 31, 2023; Buyer has 30-day due diligence period after receiving all items to terminate at its sole discretion.","Sellers prohibited from soliciting other acquisition proposals; agreement includes standard reps, warranties, and indemnification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295887,"accession_number":"0001477932-23-002688","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-04-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cosmos Health FY2022 revenue down 10.5% to $50.3M; positive adjusted EBITDA, debt reduced 76%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $50.3M vs $56.2M; constant-currency increase of $0.4M; net loss $13.8M vs $7.96M.","Adjusted EBITDA positive $0.5M (down from $3.3M in FY2021); going-concern doubt resolved.","Cash & securities $21M (vs $0.3M); long-term debt cut to $5.1M from $21.4M.","Raised $56.5M via equity/warrants; acquiring Cana Laboratories and ZipDoctor.","R&D partnership with Cloudpharm for obesity/diabetes; launched Mediterranation supplements."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":12349777.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316427,"accession_number":"0001477932-23-001328","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-03-06T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cosmos Health issues €4.1M secured note to Cana Holdings; acquisition planned by March 31, 2023","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Cosmos Health issued a €4.1M secured promissory note to Cana Holdings, bearing interest at 5% + 1-month LIBOR, maturing in 5 years.","Note is secured by share pledges over all shares of Cana Holdings and its subsidiary Cana Pharmaceutical.","This is the first step of a two-step transaction; the second step is acquisition of all Cana Holdings shares by Cosmos Health by March 31, 2023.","Proceeds may not be used for capitalization or debt repayment without Cosmos Health's consent.","Cross-default provision: a default under any other financial instrument causing Material Adverse Effect can trigger default under this note."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316426,"accession_number":"0001477932-23-000799","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-02-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cosmos Health appoints Nikos Bardakis as COO; Pavlos Ignatiades moves to CCO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nikos Bardakis appointed COO effective Feb 1, 2023, with over 20 years international pharma experience.","Bardakis previously National Sales Director at Servier Hellas, managing 130+ employees.","Pavlos Ignatiades transitions from COO to Chief Communications Officer (CCO).","Ignatiades had been COO since 2020, responsible for Nasdaq listing and investor relations.","CEO Greg Siokas states moves support multi-layered growth strategy and transformation to healthcare company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316425,"accession_number":"0001477932-23-000348","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-01-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cosmos Health CEO forfeits warrants from Dec 2022 offering due to accounting concerns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Grigorios Siokas forfeits warrants to purchase 260,870 shares to resolve executive compensation accounting issues.","Siokas retains the 260,870 shares purchased for $3M at $11.50/share in the December 2022 registered direct offering.","Amendment clarifies Siokas' allocation was determined after market close on December 19, 2022.","Independent board members approved the amendment to the Securities Purchase Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316424,"accession_number":"0001477932-23-000211","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2023-01-12T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Cosmos Health extends LOI to acquire Cana Labs; renegotiates payment terms","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Updated binding LOI to acquire Greek pharma company Cana Laboratories; effective until May 31, 2023.","Acquisition price renegotiated with improved payment terms; no dollar amount disclosed.","Cana owns a 54,000 sq ft GMP-certified production facility in Athens, Greece.","Cana has partnerships with AstraZeneca, Merck, Medtronic, Nestle, and others.","CEO says acquisition would vertically integrate manufacturing and expand product portfolio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334695,"accession_number":"0001477932-22-009427","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2022-12-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cosmos Health raises $32.5M in registered direct offering and private placement at $11.50/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$32.5M from sale of 2,828,320 shares and warrants at $11.50/unit.","Each warrant exercisable immediately at $11.50, expires in 5 years; CEO Siokas participated.","Net proceeds to be used for working capital and general corporate purposes.","A.G.P./Alliance Global Partners sole placement agent; cash fee of 6.5%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334700,"accession_number":"0001477932-22-009368","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2022-12-19T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"Cosmos Holdings 1-for-25 reverse stock split, name to Cosmos Health","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split 1-for-25 effective Dec 16, 2022; CUSIP changes to 221413-305.","Company renamed to Cosmos Health Inc. effective Dec 16, 2022.","Authorized shares unchanged: 300M common, 100M preferred.","CEO states split is required to regain Nasdaq minimum bid price compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334699,"accession_number":"0001477932-22-009080","cik":1474167,"company_name":"Cosmos Health Inc.","ticker":"COSM","form_type":"8-K","filed_at":"2022-12-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cosmos Holdings shareholders approve reverse split authorization, name change, equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected with 98-99% affirmative votes.","2022 equity incentive plan approved with 98% of votes cast in favor.","Shareholders approved name change amendment (98% affirmative) and authorized board to effect reverse stock split (98% affirmative).","Advisory say-on-pay frequency received 93% support for every three years; say-on-pay compensation approved with 98%.","Quorum of ~37% of outstanding shares (9.85M of 26.37M) was present at the December 2, 2022 meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15846573.448136551,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-12-05T23:59:59+00:00|334699"}